Latest Prasugrel Stories

2009-11-15 07:00:00

ORLANDO, Fla., Nov. 15 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced results of a PLATO sub-analysis in the most serious type of Acute Coronary Syndrome (ACS) patients, those with ST Segment Elevation Myocardial Infarction (STEMI).

2009-11-15 07:00:00

Study highlights: - A new reversible, intravenous blood thinner did not show superiority over an irreversible one currently approved for use. - Further investigation of the new anti-clotting drug is warranted. ORLANDO, Fla., Nov.

2009-10-20 06:00:00

FRANKLIN LAKES, N.J., Oct. 20 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc.

2009-09-24 14:10:00

SAN FRANCISCO, Sept. 24 /PRNewswire-FirstCall/ -- New data from the phase III PLATO study showed that ticagrelor (BRILINTA((TM))) provided greater reduction of cardiovascular (CV) events (composite of CV death, heart attack and stroke) than clopidogrel (9.02% vs.

2009-09-02 07:30:00

SAN DIEGO, Sept. 2 /PRNewswire/ -- Accumetrics, Inc. has announced the signing of a new exclusive distribution agreement for its VerifyNow(R) System in Spain, Portugal and Chile with Grifols S.A..

2009-08-31 09:43:16

Studies from a growing body of convincing data show that responsiveness to antiplatelet therapy is real. This is a clinically important issue and there is a need to develop individual antiplatelet strategies particularly for patients at risk.

2009-08-31 08:43:55

Data from a phase II trial of an investigational intravenous drug designed to block the formation of blood clots shows potential to reduce the risk of death, a second heart attack, or other coronary complications compared with the current standard of care in patients presenting with acute coronary syndromes (heart attacks or unstable angina).

Word of the Day
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.